Article Text

Download PDFPDF
Creutzfeldt-Jakob-like syndrome induced by lithium, levomepromazine, and phenobarbitone
  1. HIDEYUKI KIKYO
  1. Shemaron 201, 3–12–28 Negishi, Taito-ku
  2. Tokyo 110, Japan
  3. 1–5–45 Yushima Bunkyo-ku, Tokyo 113, Japan
  1. Dr Hideyuki Kikyo, Department of Neurology, Tokyo Medical and Dental University, Tokyo, Japan. email:kikyo{at}m.u-tokyo.ac.jp
  1. TETSUO FURUKAWA
  1. Shemaron 201, 3–12–28 Negishi, Taito-ku
  2. Tokyo 110, Japan
  3. 1–5–45 Yushima Bunkyo-ku, Tokyo 113, Japan
  1. Dr Hideyuki Kikyo, Department of Neurology, Tokyo Medical and Dental University, Tokyo, Japan. email:kikyo{at}m.u-tokyo.ac.jp

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Creutzfeldt-Jakob-like syndrome was first reported by Smith and Kocen1 in 1988. Its symptoms resemble Creutzfeldt-Jakob disease but it is induced by drugs, particularly lithium, and most patients recover without sequel after discontinuation of drugs. It also displays a characteristic EEG similar to Creutzfeldt-Jakob disease, but this returns to normal when the patient recovers.

There have been some case reports of Creutzfeldt-Jakob-like syndrome after that of Smith et al (table), but no paper seems to have described the detailed course of EEG changes. This paper presents a case of Creutzfeldt-Jakob-like syndrome possibly induced by lithium, levomepromazine, and phenobarbitone, in which we succeeded in recording the course of EEG changes.

View this table:

Creutzfeldt-Jakob-like syndrome related to lithium

A 65 year old woman was admitted to a hospital with coma and myoclonus. She had a history of manic and …

View Full Text